|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
c7cc656a-3991-4358-9239-ca76ef4770e8 |
| 005 |
20240707000000.0 |
| 008 |
000407s2000 nyua b 001 0 eng c |
| 010 |
|
|
|a 00038333
|
| 020 |
|
|
|a 0824776658 (alk. paper)
|
| 035 |
|
|
|a (OCoLC)43854196
|
| 040 |
|
|
|a NLM
|c NLM
|d MnU-B
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 049 |
|
|
|a UMMA
|
| 050 |
|
4 |
|a RB155.8
|
| 060 |
1 |
0 |
|a QZ 50
|b G3217 2000
|
| 245 |
0 |
0 |
|a Gene therapy :
|b therapeutic mechanisms and strategies /
|c edited by Nancy Smyth Templeton, Danilo D. Lasic.
|
| 260 |
|
|
|a New York :
|b Dekker,
|c ©2000.
|
| 300 |
|
|
|a xv, 584 pages :
|b illustrations ;
|c 29 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Foreword /
|r Philip D. Noguchi --
|g Pt. I.
|t Viral Delivery and Therapeutic Strategies.
|g 1.
|t Retroviral Vectors for Gene Therapy /
|r Paula M. Cannon and W. French Anderson.
|g 2.
|t Adenovirus Vectors for Gene Therapy /
|r Neil R. Hackett and Ronald G. Crystal.
|g 3.
|t Adeno-Associated Virus and Adeno-Associated Virus Vectors for Gene Delivery /
|r Barrie J. Carter.
|g 4.
|t Ex Vivo Gene Therapy Using Myoblasts and Regulatable Retroviral Vectors /
|r Clare R. Ozawa, Matthew L. Springer and Helen M. Blau.
|g 5.
|t Design and Use of Herpes Simplex Viral Vectors for Gene Therapy /
|r Darren Wolfe, William F. Goins and David J. Fink /
|r [et al.].
|g 6.
|t Alphavirus-Based Vectors for Vaccine and Gene Therapy Applications /
|r Thomas W. Dubensky, Jr., John M. Polo and Douglas J. Jolly --
|g Pt. II.
|t Nonviral Delivery and Therapeutic Strategies.
|g 7.
|t Gene Delivery with Polyethylenimine /
|r S. M. Zou, Jean-Paul Behr and D. Goula /
|r [et al.].
|g 8.
|t Receptor-Mediated Gene Transfer /
|r Kurosh Ameri and Ernst Wagner.
|9 bnatoc
|
| 505 |
8 |
0 |
|g 9.
|t Modification of Melanoma Cells via Ballistic Gene Delivery for Vaccination /
|r Ulrich R. Hengge and Dirk Schadendorf.
|g 10.
|t Polymer-Encapsulated Cells for Gene Therapy /
|r Dwaine F. Emerich and Elizabeth Razee.
|g 11.
|t Molecular Interactions in Lipids, DNA, and DNA-Lipid Complexes /
|r Rudolf Podgornik, Helmut H. Strey and V. A. Parsegian.
|g 12.
|t Bioorganic Colloids: Macromolecules, DNA, Self-Assembled Particles, and Their Complexes /
|r Danilo D. Lasic and Nancy Smyth Templeton.
|g 13.
|t Synthetic Virus Systems for Systemic Gene Therapy /
|r Ian MacLachlan, Pieter Cullis and Roger W. Graham --
|g Pt. III.
|t Other Therapeutic Strategies and Regulatory Aspects.
|g 14.
|t Gene Therapy Applications of Ribozymes /
|r Bruce A. Sullenger and Lynn Milich.
|g 15.
|t Antisense Oligonucleotide - Based Therapeutics /
|r C. Frank Bennett, Madeline Butler and P. Dan Cook /
|r [et al.].
|g 16.
|t Selectable Markers for Gene Therapy /
|r Michael M. Gottesman, Thomas Licht and Yi Zhou /
|r [et al.].
|9 bnatoc
|
| 505 |
8 |
0 |
|g 17.
|t Suicide Gene Therapy /
|r Bert W. O'Malley, Jr.
|g 18.
|t Regulatory Aspects of Gene Therapy /
|r Andra E. Miller and Stephanie L. Simek --
|g Pt. IV.
|t Disease Targets and Therapeutic Strategies.
|g 19.
|t Gene Transfer into Hematopoietic Stem Cells /
|r David M. Bodine.
|g 20.
|t Gene Therapy for Hematopoietic Disorders /
|r Mitchell E. Horwitz and Harry L. Malech.
|g 21.
|t Gene Therapy for Cardiovascular Disease and Vascular Grafts /
|r Afshin Ehsan, Michael J. Mann and Victor J. Dzau.
|g 22.
|t Gene Therapy for Cancer /
|r Karsten Brand, Gerhard Wolff and Michael Strauss.
|g 23.
|t Barriers to Efficient Airway Epithelial Gene Transfer: Lessons from Cystic Fibrosis /
|r Larry G. Johnson and Richard C. Boucher.
|g 24.
|t Gene Transfer to the Central Nervous System /
|r Ulrike Blomer, I. M. Verma and F. H. Gage.
|g 25.
|t Principles of Gene Therapy for Inborn Errors of Metabolism /
|r Jon A. Wolff and Cary O. Harding.
|g 26.
|t Gene Therapy and HIV-1 Infection /
|r Ralph Dornburg and Roger J. Pomerantz.
|9 bnatoc
|
| 505 |
8 |
0 |
|g 27.
|t Gene Delivery to the Skin /
|r Paul A. Khavari.
|g 28.
|t DNA Vaccines /
|r Jong J. Kim and David B. Weiner.
|9 bnatoc
|
| 650 |
|
0 |
|a Gene therapy
|x Methodology.
|
| 650 |
1 |
2 |
|a Genetic Therapy
|x methods
|
| 700 |
1 |
|
|a Templeton, Nancy Smyth,
|d 1952-
|
| 700 |
1 |
|
|a Lasic, D. D.
|
| 999 |
1 |
0 |
|i c7cc656a-3991-4358-9239-ca76ef4770e8
|l 9945517560001701
|s US-MNU
|m gene_therapytherapeutic_mechanisms_and_strategies__________________________2000_______dekkea___________________________________________________________________________p
|
| 999 |
1 |
0 |
|i c7cc656a-3991-4358-9239-ca76ef4770e8
|l 990019358190104321
|s US-MNWINOS
|m gene_therapytherapeutic_mechanisms_and_strategies__________________________2000_______dekkea___________________________________________________________________________p
|
| 999 |
1 |
1 |
|l 9945517560001701
|s ISIL:US-MNU
|i University of Minnesota
|t BKS
|a TBIOMGENS
|c QZ50 G3217 2000
|d NLM
|b 31951D01977827Z
|x BOOK
|y 23447331380001701
|p LOANABLE
|
| 999 |
1 |
1 |
|l 990019358190104321
|s ISIL:US-MNWINOS
|i Winona State University
|t BKS
|a MAIN
|c RB155.8 .G462 2000
|b 30106003915880
|x BOOK
|y 2345351410004321
|p LOANABLE
|